133 related articles for article (PubMed ID: 32641517)
1. Exposure of Patient-Derived Mesenchymal Stromal Cells to TGFB1 Supports Fibrosis Induction in a Pediatric Acute Megakaryoblastic Leukemia Model.
Hack T; Bertram S; Blair H; Börger V; Büsche G; Denson L; Fruth E; Giebel B; Heidenreich O; Klein-Hitpass L; Kollipara L; Sendker S; Sickmann A; Walter C; von Neuhoff N; Hanenberg H; Reinhardt D; Schneider M; Rasche M
Mol Cancer Res; 2020 Oct; 18(10):1603-1612. PubMed ID: 32641517
[TBL] [Abstract][Full Text] [Related]
2. Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype.
Wang L; Peters JM; Fuda F; Li L; Karandikar NJ; Koduru P; Wang HY; Chen W
Cytometry B Clin Cytom; 2015; 88(4):244-52. PubMed ID: 25361478
[TBL] [Abstract][Full Text] [Related]
3. Reduction of Graft-versus-Host-Disease in NOD.Cg-Prkdc
Hansen M; Stahl L; Heider A; Hilger N; Sack U; Kirschner A; Cross M; Fricke S
Transplant Cell Ther; 2021 Aug; 27(8):658.e1-658.e10. PubMed ID: 33964513
[TBL] [Abstract][Full Text] [Related]
4. Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS).
Pelleri MC; Piovesan A; Caracausi M; Berardi AC; Vitale L; Strippoli P
BMC Med Genomics; 2014 Dec; 7():63. PubMed ID: 25476127
[TBL] [Abstract][Full Text] [Related]
5. Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia With Unusual Immunophenotype.
Koulmane Laxminarayana SL; Kohli S; Agrohi J; Belurkar S
Cureus; 2023 Mar; 15(3):e35965. PubMed ID: 36911590
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
[TBL] [Abstract][Full Text] [Related]
8. Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution.
Su N; Li Z; Yang J; Fu Y; Zhu X; Miao H; Yu Y; Jiang W; Le J; Qian X; Wang H; Qian M; Zhai X
Front Oncol; 2022; 12():915833. PubMed ID: 36003795
[TBL] [Abstract][Full Text] [Related]
9. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
[TBL] [Abstract][Full Text] [Related]
10. Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development.
Li J; Kalev-Zylinska ML
Front Cell Dev Biol; 2023; 11():1170622. PubMed ID: 37325571
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
12. Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
Borella G; Da Ros A; Borile G; Porcù E; Tregnago C; Benetton M; Marchetti A; Bisio V; Montini B; Michielotto B; Cani A; Leszl A; Campodoni E; Sandri M; Montesi M; Bresolin S; Cairo S; Buldini B; Locatelli F; Pigazzi M
Blood; 2021 Aug; 138(7):557-570. PubMed ID: 34010415
[TBL] [Abstract][Full Text] [Related]
13. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD
Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651
[TBL] [Abstract][Full Text] [Related]
14. Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric
Huang J; Hu G; Suo P; Bai L; Cheng Y; Wang Y; Zhang X; Liu K; Sun Y; Xu L; Kong J; Yan C; Huang X
Front Oncol; 2023; 13():1116205. PubMed ID: 36874138
[TBL] [Abstract][Full Text] [Related]
15. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
[TBL] [Abstract][Full Text] [Related]
16. Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities.
Cardin S; Bilodeau M; Roussy M; Aubert L; Milan T; Jouan L; Rouette A; Laramée L; Gendron P; Duchaine J; Decaluwe H; Spinella JF; Mourad S; Couture F; Sinnett D; Haddad É; Landry JR; Ma J; Humphries RK; Roux PP; Hébert J; Gruber TA; Wilhelm BT; Cellot S
Blood Adv; 2019 Nov; 3(21):3307-3321. PubMed ID: 31698461
[TBL] [Abstract][Full Text] [Related]
17. Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome.
Malinge S; Bliss-Moreau M; Kirsammer G; Diebold L; Chlon T; Gurbuxani S; Crispino JD
J Clin Invest; 2012 Mar; 122(3):948-62. PubMed ID: 22354171
[TBL] [Abstract][Full Text] [Related]
18. CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome.
Savaşan S; Buck S; Raimondi SC; Becton DL; Weinstein H; Chang M; Ravindranath Y
Leuk Lymphoma; 2006 Oct; 47(10):2076-83. PubMed ID: 17071479
[TBL] [Abstract][Full Text] [Related]
19. Effects of mesenchymal stromal cells on human myeloid dendritic cell differentiation and maturation in a humanized mouse model.
Chen P; Huang Y; Womer KL
J Immunol Methods; 2015 Dec; 427():100-4. PubMed ID: 26522667
[TBL] [Abstract][Full Text] [Related]
20. Pan myeloid antigen-negative pediatric acute megakaryoblastic leukemia.
Cetin N; Lorsbach RB
Pediatr Blood Cancer; 2014 Nov; 61(11):2089-91. PubMed ID: 24962432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]